Bio-Techne Corp (TECH)
62.66
-0.86
(-1.35%)
USD |
NASDAQ |
Apr 25, 16:00
62.68
+0.02
(+0.03%)
After-Hours: 20:00
Bio-Techne Total Liabilities (Quarterly): 767.19M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 767.19M |
| September 30, 2023 | 757.61M |
| June 30, 2023 | 672.18M |
| March 31, 2023 | 710.01M |
| December 31, 2022 | 536.30M |
| September 30, 2022 | 599.57M |
| June 30, 2022 | 593.79M |
| March 31, 2022 | 586.57M |
| December 31, 2021 | 602.32M |
| September 30, 2021 | 623.23M |
| June 30, 2021 | 691.72M |
| March 31, 2021 | 536.70M |
| December 31, 2020 | 537.01M |
| September 30, 2020 | 613.81M |
| June 30, 2020 | 646.40M |
| March 31, 2020 | 707.75M |
| December 31, 2019 | 675.07M |
| September 30, 2019 | 750.80M |
| June 30, 2019 | 718.82M |
| March 31, 2019 | 726.35M |
| December 31, 2018 | 748.41M |
| September 30, 2018 | 762.73M |
| June 30, 2018 | 514.14M |
| March 31, 2018 | 559.52M |
| December 31, 2017 | 557.60M |
| Date | Value |
|---|---|
| September 30, 2017 | 567.57M |
| June 30, 2017 | 608.59M |
| March 31, 2017 | 625.51M |
| December 31, 2016 | 629.45M |
| September 30, 2016 | 622.08M |
| June 30, 2016 | 250.30M |
| March 31, 2016 | 268.96M |
| December 31, 2015 | 277.11M |
| September 30, 2015 | 290.37M |
| June 30, 2015 | 216.42M |
| March 31, 2015 | 284.24M |
| December 31, 2014 | 298.32M |
| September 30, 2014 | 224.85M |
| June 30, 2014 | 67.23M |
| March 31, 2014 | 53.52M |
| December 31, 2013 | 53.64M |
| September 30, 2013 | 52.53M |
| June 30, 2013 | 40.56M |
| March 31, 2013 | 40.78M |
| December 31, 2012 | 30.00M |
| September 30, 2012 | 32.02M |
| June 30, 2012 | 44.88M |
| March 31, 2012 | 39.54M |
| December 31, 2011 | 26.74M |
| September 30, 2011 | 39.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
536.30M
Minimum
Dec 2022
767.19M
Maximum
Dec 2023
648.78M
Average
646.40M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies Inc | 4.76B |
| Bio-Rad Laboratories Inc | 3.558B |
| Revvity Inc | 5.692B |
| Twist Bioscience Corp | 142.77M |
| AIM ImmunoTech Inc | 9.147M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.731B |
| Shareholders Equity (Quarterly) | 1.964B |
| Debt to Equity Ratio | 0.2276 |
| Current Ratio | 4.368 |
| Net Debt Paydown Yield | -0.30% |